Diabetes vaccine gives promising results in a genetic subgroup

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
A clinical study led by Linköping University and financed by pharmaceuticals company Diamyd Medical has investigated whether immunotherapy against type 1 diabetes can preserve the body's own production of insulin. The results suggest that injection of a protein, GAD, into lymph nodes can be effective in a subgroup of individuals. The results have been published in Diabetes Care.

In type 1 diabetes, the body's immune system attacks the cells that produce insulin. When the insulin-producing cells have disappeared, the body can no longer regulate blood sugar level, and a person with type 1 diabetes must take exogenous insulin for the rest of his or her life.


Interesting 🙂
 
Status
Not open for further replies.
Back
Top